Literature DB >> 33991583

ROS-induced cell cycle arrest as a mechanism of resistance in polyaneuploid cancer cells (PACCs).

Morgan D Kuczler1, Athen M Olseen2, Kenneth J Pienta2, Sarah R Amend2.   

Abstract

Cancer is responsible for the deaths of millions of people worldwide each year. Once metastasized, the disease is incurable and shows resistance to all anti-cancer therapies. The already-elevated level of reactive oxygen species (ROS) in cancer cells is further increased by therapies. The oxidative stress activates the DNA damage response (DDR) and the stressed cancer cell moves towards cell cycle arrest. Once arrested, the majority of cancer cells will undergo programmed cell death in the form of apoptosis. If the cancer cell is able to exit the cell cycle prior to cell division and enter a protected G0 state, it is able to withstand and survive therapy as a polyaneuploid cancer cell (PACC) and eventually seed resistant tumor growth.
Copyright © 2021 The Authors. Published by Elsevier Ltd.. All rights reserved.

Entities:  

Keywords:  Cell cycle; Polyaneuploid cancer cell (PACC); Polyploid giant cancer cell (PGCC); Reactive oxygen species; Therapy resistance

Mesh:

Substances:

Year:  2021        PMID: 33991583      PMCID: PMC8511226          DOI: 10.1016/j.pbiomolbio.2021.05.002

Source DB:  PubMed          Journal:  Prog Biophys Mol Biol        ISSN: 0079-6107            Impact factor:   4.799


  49 in total

Review 1.  Reactive oxygen species (ROS) homeostasis and redox regulation in cellular signaling.

Authors:  Paul D Ray; Bo-Wen Huang; Yoshiaki Tsuji
Journal:  Cell Signal       Date:  2012-01-20       Impact factor: 4.315

2.  Radiation-induced cellular senescence results from a slippage of long-term G2 arrested cells into G1 phase.

Authors:  Caiyong Ye; Xurui Zhang; Jianghua Wan; Lei Chang; Wentao Hu; Zhitong Bing; Sheng Zhang; Junhong Li; Jinpeng He; Jufang Wang; Guangming Zhou
Journal:  Cell Cycle       Date:  2013-04-09       Impact factor: 4.534

3.  DNA damage-induced reactive oxygen species (ROS) stress response in Saccharomyces cerevisiae.

Authors:  Lori A Rowe; Natalya Degtyareva; Paul W Doetsch
Journal:  Free Radic Biol Med       Date:  2008-07-30       Impact factor: 7.376

Review 4.  Convergent Evolution, Evolving Evolvability, and the Origins of Lethal Cancer.

Authors:  Kenneth J Pienta; Emma U Hammarlund; Robert Axelrod; Sarah R Amend; Joel S Brown
Journal:  Mol Cancer Res       Date:  2020-03-31       Impact factor: 5.852

Review 5.  Live to die another way: modes of programmed cell death and the signals emanating from dying cells.

Authors:  Yaron Fuchs; Hermann Steller
Journal:  Nat Rev Mol Cell Biol       Date:  2015-05-20       Impact factor: 94.444

Review 6.  The DNA damage response and cancer therapy.

Authors:  Christopher J Lord; Alan Ashworth
Journal:  Nature       Date:  2012-01-18       Impact factor: 49.962

7.  DNA damaging agents and p53 do not cause senescence in quiescent cells, while consecutive re-activation of mTOR is associated with conversion to senescence.

Authors:  Olga V Leontieva; Mikhail V Blagosklonny
Journal:  Aging (Albany NY)       Date:  2010-12       Impact factor: 5.682

Review 8.  Targeting Oxidatively Induced DNA Damage Response in Cancer: Opportunities for Novel Cancer Therapies.

Authors:  Pierpaola Davalli; Gaetano Marverti; Angela Lauriola; Domenico D'Arca
Journal:  Oxid Med Cell Longev       Date:  2018-03-27       Impact factor: 6.543

Review 9.  Reactive Oxygen Species: A Key Constituent in Cancer Survival.

Authors:  Seema Kumari; Anil Kumar Badana; Murali Mohan G; Shailender G; RamaRao Malla
Journal:  Biomark Insights       Date:  2018-02-06

10.  Estimating the global cancer incidence and mortality in 2018: GLOBOCAN sources and methods.

Authors:  J Ferlay; M Colombet; I Soerjomataram; C Mathers; D M Parkin; M Piñeros; A Znaor; F Bray
Journal:  Int J Cancer       Date:  2018-12-06       Impact factor: 7.396

View more
  7 in total

1.  Cedrus libani tar prompts reactive oxygen species toxicity and DNA damage in colon cancer cells.

Authors:  Ebru Temiz; Kadir Eği; Ismail Koyuncu; Ozgür Yüksekdag; Yusuf Kurt; Murat Tiken; Sükrü Akmese
Journal:  Mol Biol Rep       Date:  2022-06-06       Impact factor: 2.742

2.  A life history model of the ecological and evolutionary dynamics of polyaneuploid cancer cells.

Authors:  Anuraag Bukkuri; Kenneth J Pienta; Robert H Austin; Emma U Hammarlund; Sarah R Amend; Joel S Brown
Journal:  Sci Rep       Date:  2022-08-12       Impact factor: 4.996

3.  Stochastic models of Mendelian and reverse transcriptional inheritance in state-structured cancer populations.

Authors:  Anuraag Bukkuri; Kenneth J Pienta; Robert H Austin; Emma U Hammarlund; Sarah R Amend; Joel S Brown
Journal:  Sci Rep       Date:  2022-07-29       Impact factor: 4.996

4.  The potential inhibitory effect of ginsenoside Rh2 on mitophagy in UV-irradiated human dermal fibroblasts.

Authors:  Hyunji Lee; Gyeyeong Kong; Jisoo Park; Jongsun Park
Journal:  J Ginseng Res       Date:  2022-02-09       Impact factor: 5.735

5.  EZH2 Regulates ANXA6 Expression via H3K27me3 and Is Involved in Angiotensin II-Induced Vascular Smooth Muscle Cell Senescence.

Authors:  Yuejin Li; Shikui Guo; Yingpeng Zhao; Rougang Li; Yu Li; Changtao Qiu; Le Xiao; Kunmei Gong
Journal:  Oxid Med Cell Longev       Date:  2022-09-14       Impact factor: 7.310

6.  Colchicine as a novel drug for the treatment of osteosarcoma through drug repositioning based on an FDA drug library.

Authors:  Jisun Oh; Hyun Ju An; Hyun Jeong Yeo; Sujin Choi; Jisu Oh; Segi Kim; Jin Man Kim; Junwon Choi; Soonchul Lee
Journal:  Front Oncol       Date:  2022-08-18       Impact factor: 5.738

7.  Auranofin induces urothelial carcinoma cell death via reactive oxygen species production and synergy with cisplatin.

Authors:  San-Yuan Chen; Chun-Nun Chao; Hsin-Yi Huang; Chiung-Yao Fang
Journal:  Oncol Lett       Date:  2021-12-27       Impact factor: 2.967

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.